Literature DB >> 4777061

Evolution of a practical policy for chemotherapy of carcinoma of the breast.

M L Sutton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4777061      PMCID: PMC1645336     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  7 in total

1.  EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIV. FURTHER STUDY OF CERTAIN BASIC CONCEPTS UNDERLYING CHEMOTHERAPY OF LEUKEMIA.

Authors:  H E SKIPPER; F M SCHABEL; W S WILCOX
Journal:  Cancer Chemother Rep       Date:  1965-04

Review 2.  Combination cancer therapy: Presidential address.

Authors:  E Frei
Journal:  Cancer Res       Date:  1972-12       Impact factor: 12.701

3.  Combination chemotherapy using cyclophosphamide, vincristine, methotrexate and 5-fluorouracil in solid tumors.

Authors:  J J Costanzi; C A Coltman
Journal:  Cancer       Date:  1969-03       Impact factor: 6.860

4.  Five-drug therapy for advanced breast cancer: a phase I study.

Authors:  F J Ansfield; G Ramirez; B C Korbitz; H L Davis
Journal:  Cancer Chemother Rep       Date:  1971-04

5.  Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo.

Authors:  W R Bruce; B E Meeker; F A Valeriote
Journal:  J Natl Cancer Inst       Date:  1966-08       Impact factor: 13.506

6.  Tumour growth and anti-mitotic action. The role of spontaneous cell losses.

Authors:  K D Bagshawe
Journal:  Br J Cancer       Date:  1968-12       Impact factor: 7.640

7.  Seventy-five cases of solid tumours treated by a modified quadruple chemotherapy regime.

Authors:  I W Hanham; K A Newton; G Westbury
Journal:  Br J Cancer       Date:  1971-09       Impact factor: 7.640

  7 in total
  1 in total

1.  Carcinoma of the breast in the Section of Radiology.

Authors:  W M Ross
Journal:  J R Soc Med       Date:  1980-10       Impact factor: 18.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.